Skip to main content

ICPE 2022 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Hengrui Sun

U.S. Food and Drug Administration

Poster(s):

(Y) Use of Valganciclovir/Ganciclovir [(v)GCV] for Treatment of Congenital Cytomegalovirus (cCMV) Infection in the United States: Evidence from The Sentinel Distributed Database, 2008-2020
Sunday, August 28, 2022
8:00 AM – 6:00 PM CEST